←NVO · $38.54
Novo Nordisk
NVO · After hours
$38.54
+0.83% today·exchange $38.54
exchange $38.54
About
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
- Industry
- Healthcare
- CEO
- Maziar Mike Doustdar